Intercept Surges To Four-Month High After Staving Off Amneal's Generic For 11 Years

Intercept Surges To Four-Month High After Staving Off Amneal's Generic For 11 Years

Intercept reached a settlement with Amneal that delays a generic version of its only product. In response, ICPT stock surged Wednesday.